Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
DNA Polymerase Market size was valued at US$ 342.6 million in 2023 and is poised to grow at a CAGR of 5.9% from 2024-2030. DNA polymerases are the enzymes that help in the synthesis of DNA molecules from deoxyribonucleotides. DNA polymerases are essential for DNA replication and work in pairs to synthesize two identical DNA strands from a single original DNA molecule. During the process of DNA polymerization, DNA polymerase reads the existing DNA strands to create newer stands that match with existing ones. DNA polymerase adds the nucleotides to the end of the DNA strand.
During the cell division, DNA polymerases help to duplicate the cell DNA and copy of original DNA molecule passed to each daughter cell. Through this process, genetic information is passed from generation to generation. An increase in R&D activities in the life sciences sector, a rise in preference for high-quality tools in epigenetic research, the development of novel molecular diagnostics tools for disease diagnosis, and an increase in the usage of high-fidelity DNA polymerase are anticipated to fuel the market over the forecast period. Moreover, a wide range of applications of DNA polymerase, an increase in funding from public and private sectors for R&D, and increased DNA polymerase usage in the biopharmaceutical industry are expected to propel the market. However, the high cost of DNA polymerase products and the availability of alternative products are expected to hinder the growth of the market over the forecast timeframe.
Study Period
2024-2030Base Year
2023CAGR
5.9%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The market is growing at significant rate over the decade owing to increase in DNA polymerase usage in various industries such as forensic science, biopharmaceuticals, research centers, and diagnostic centers among others. DNA polymerase plays major role in various biotechnological techniques such as polymerase chain reaction (PCR), DNA cloning, DNA sequencing, single nucleotide polymorphism, whole genome amplification, and molecular diagnostics. Moreover, collaborations, launching of newer DNA polymerase enzymes, and patent approval are the key strategies followed by market players. For instance, in April 2013, Sygnis granted US patent for Qualiphi, a DNA polymerase has potential to improve the complete DNA amplification with minimal concentrations. Similarly, in September 2016, a subsidiary of Biotec Pharmacon ASA launched isothermal DNA polymerase IsoPolTM and also the company received patent protection for its heat-labile Salt Active Nucleases (SAN) in U.S.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market growing due to increase in the R&D activities by biopharmaceutical companies, presence of huge number of academic research institutes, and development of newer drugs and diagnostic techniques are fuelling the market. Europe is growing at a significant rate owing to increase in the R&D activities by research institutes, raise in funding from the government, and availability of skilled researchers in the region. Asia Pacific is poised to grow due to increase in the prevalence of cancer in China, India, and Japan, growing forensic services, and increase in diagnostic centers in Asia Pacific region are bolster the market. Latin America market has lucrative growth opportunities owing to increase in prevalence of various chronic diseases such as Cancer and HIV in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 342.6 million |
|
Market CAGR |
5.9% |
|
By Product Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global DNA polymerase market size was valued at US$ 342.6 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Novus Biologicals (Bio-Techne) (U.S.) Sygnis AG (Germany) Biomiga, Inc. (U.S.) New England Biolabs (U.S.) Hoffmann-la Roche (Switzerland)
| 1. Executive Summary |
| 2. Global DNA Polymerase Market Introduction |
| 2.1.Global DNA Polymerase Market - Taxonomy |
| 2.2.Global DNA Polymerase Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End User |
| 2.2.3.Geography |
| 2.2.4.Region |
| 3. Global DNA Polymerase Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global DNA Polymerase Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global DNA Polymerase Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Prokaryotic DNA Polymerase |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Eukaryotic DNA Polymerase |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global DNA Polymerase Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Pharmaceutical and Biotechnology Companies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Academic and Research Institutes |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diagnostic Centers |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global DNA Polymerase Market By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Asia Pacific |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Latin America |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Europe |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global DNA Polymerase Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America DNA Polymerase Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Prokaryotic DNA Polymerase |
| 9.1.2.Eukaryotic DNA Polymerase |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Pharmaceutical and Biotechnology Companies |
| 9.2.2.Academic and Research Institutes |
| 9.2.3.Diagnostic Centers |
| 9.2.4.Others |
| 9.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.North America |
| 9.3.2.Asia Pacific |
| 9.3.3.Latin America |
| 9.3.4.Europe |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe DNA Polymerase Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Prokaryotic DNA Polymerase |
| 10.1.2.Eukaryotic DNA Polymerase |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Pharmaceutical and Biotechnology Companies |
| 10.2.2.Academic and Research Institutes |
| 10.2.3.Diagnostic Centers |
| 10.2.4.Others |
| 10.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.North America |
| 10.3.2.Asia Pacific |
| 10.3.3.Latin America |
| 10.3.4.Europe |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) DNA Polymerase Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Prokaryotic DNA Polymerase |
| 11.1.2.Eukaryotic DNA Polymerase |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Pharmaceutical and Biotechnology Companies |
| 11.2.2.Academic and Research Institutes |
| 11.2.3.Diagnostic Centers |
| 11.2.4.Others |
| 11.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.North America |
| 11.3.2.Asia Pacific |
| 11.3.3.Latin America |
| 11.3.4.Europe |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) DNA Polymerase Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Prokaryotic DNA Polymerase |
| 12.1.2.Eukaryotic DNA Polymerase |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Pharmaceutical and Biotechnology Companies |
| 12.2.2.Academic and Research Institutes |
| 12.2.3.Diagnostic Centers |
| 12.2.4.Others |
| 12.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.North America |
| 12.3.2.Asia Pacific |
| 12.3.3.Latin America |
| 12.3.4.Europe |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America DNA Polymerase Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Prokaryotic DNA Polymerase |
| 13.1.2.Eukaryotic DNA Polymerase |
| 13.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Pharmaceutical and Biotechnology Companies |
| 13.2.2.Academic and Research Institutes |
| 13.2.3.Diagnostic Centers |
| 13.2.4.Others |
| 13.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.North America |
| 13.3.2.Asia Pacific |
| 13.3.3.Latin America |
| 13.3.4.Europe |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) |
| 14.2.1.Novus Biologicals (Bio-Techne) (U.S.) |
| 14.2.2.Sygnis AG (Germany) |
| 14.2.3.Biomiga, Inc. (U.S.) |
| 14.2.4.New England Biolabs (U.S.) |
| 14.2.5.Hoffmann-la Roche (Switzerland) |
| 14.2.6.Illumina, Inc. (U.S.) |
| 14.2.7.Qiagen (Germany) |
| 14.2.8.Thermo Fisher Scientific (U.S.) |
| 14.2.9.Agilent Technologies (U.S.) |
| 14.2.10.Merck KGaA (Germany) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.